comparemela.com

Latest Breaking News On - Central drugs standard control organisation of india - Page 1 : comparemela.com

​​Boehringer s Jardiance now gets CDSCO nod for chronic kidney disease

The Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of chronic kidney disease (CKD). This approval allows nephrologists and cardiologists to use Jardiance for eligible CKD patients, reducing hospitalizations and addressing unmet medical needs.

28th ISCB International Conference in Rajkot to highlight latest global trends in pharmaceutical research

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.